A Birmingham hospital has opened a state-of-the-art regenerative medicine laboratory thanks to a significant legacy gift from a former patient.
In 2014, former Royal Orthopaedic Hospital (ROH) patient, Mr Michael Dubrowsky passed away and left a significant legacy gift to the ROH Charitable Fund following treatment he received at the Trust for chondrosarcoma, a rare form of bone cancer. The generous gift has enabled the hospital to invest in a new state of the art regenerative medicine laboratory which has been named The Dubrowsky Regenerative Medicine Laboratory.
The laboratory was officially opened on Tuesday 17 December 2019 by Dame Yve Buckland, Chair of the ROH.
Located close to theatres on the main ROH estate, the lab will have a focus on chondrosarcoma and cartilage research and will enable ROH to continue to lead the scientific community in the development of understanding and treatments for this rare disease.
Professor Phil Begg, Executive Director of Strategy at ROH said: “This new laboratory will enable our Trust to conduct even more ground-breaking research into rare cancers and orthopaedic treatments. The legacy of Michael Dubrowsky is monumental and will have an impact for many years to come.”
